Abdominal Operations After Left Ventricular Assist Device Implantation and Heart Transplantation

被引:5
|
作者
Sanaiha, Yas [1 ]
Xing, Hanning [1 ]
Morales, Ricardo Rosales [1 ]
Morchi, Ravi [1 ,2 ]
Ragalie, William [1 ]
Benharash, Peyman [1 ]
机构
[1] Univ Calif Los Angeles, UCLA David Geffen Sch Med, Cardiovasc Outcomes Res Labs CORELAB, Div Cardiac Surg, Los Angeles, CA USA
[2] Univ Calif Orange, Dept Gen Surg, Orange, CA USA
关键词
Orthotopic heart transplantation; Left ventricular assist device; National inpatient sample; Abdominal complications; Emergency general surgery; GASTROINTESTINAL COMPLICATIONS; CARDIAC-SURGERY; NATIONAL TRENDS; CANDIDATES; MORTALITY; OUTCOMES; CARE; ERA;
D O I
10.1016/j.jss.2019.06.045
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Left ventricular assist devices (LVADs) are increasingly used to supplant the limited number of orthotopic heart transplantation (OHT). The present study aimed to perform a contemporary analysis of emergency abdominal operations after LVAD and OHT at a national level. Methods: The 2005-2015 National Impatient Sample, the largest all-payer hospitalization database in the United States, was used to identify all adult patients who had received LVAD or OHT. The primary outcome of interest was the rate of emergency general surgery (EGS), which included laparotomy, small or large bowel resection, peptic ulcer operation, adhesiolysis, and cholecystectomy, during the same hospitalization as LVAD or OHT. Logistic regression was used to determine risk factors for EGS as well as the association between EGS and mortality in both the LVAD and OHT populations. Results: Of the estimated 19,395 OHT and 23,441 LVAD performed, 445 (2.3%) OHT and 719 (3.1%) LVAD patients required EGS. The incidence of EGS in LVAD decreased from 5.4 to 3.3%, whereas it increased among OHT patients from 1.9 to 3.7%, P = 0.003. Occurrence of EGS after OHT and LVAD was associated with significantly higher inpatient risk-adjusted mortality (OHT adjusted odds ratio, 3.0; P = 0.004; LVAD adjusted odds ratio, 2.5; P < 0.001), incremental hospitalization costs (OHT, $ 106,778; P < 0.001; LVAD, $ 61,965; P < 0.001), and length of stay (OHT, 27.9 d; P < 0.001; LVAD, 20.8 d; P < 0.001). Conclusions: EGS remains an infrequent but high mortality and cost complication of OHT and LVAD. Further investigation of the impact of immunosuppression, anticoagulation, and perfusion strategies on incidence of abdominal complications is warranted. (C) 2019 Published by Elsevier Inc.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 50 条
  • [1] Humoral and hemodynamic responses after left ventricular assist device implantation and heart transplantation
    Wagner, Frank D.
    Buz, Semih
    Zais, Hans
    Stasch, Johannes Peter
    Hetzer, Roland
    Hocher, Berthold
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 861 - 864
  • [2] Left ventricular assist device implantation in patients with a history of malignancy
    Hong, Yeahwa
    Seese, Laura
    Hickey, Gavin
    Chen, Shangzhen
    Mathier, Michael A.
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (09) : 2224 - 2231
  • [3] Racial disparities in in-hospital outcomes after left ventricular assist device implantation
    Ueyama, Hiroki
    Malik, Aaqib
    Kuno, Toshiki
    Yokoyama, Yujiro
    Briasouli, Artemis
    Shetty, Suchith
    Briasoulis, Alexandros
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (10) : 2633 - 2639
  • [4] ECMO as a Bridge to Left Ventricular Assist Device or Heart Transplantation
    DeFilippis, Ersilia M.
    Clerkin, Kevin
    Truby, Lauren K.
    Francke, Michael
    Fried, Justin
    Masoumi, Amirali
    Garan, A. Reshad
    Farr, Maryjane A.
    Takayama, Hiroo
    Takeda, Koji
    Uriel, Nir
    Topkara, Veli K.
    JACC-HEART FAILURE, 2021, 9 (04) : 281 - 289
  • [5] Frailty and outcomes after implantation of left ventricular assist device as destination therapy
    Dunlay, Shannon M.
    Park, Soon J.
    Joyce, Lyle D.
    Daly, Richard C.
    Stulak, John M.
    McNallan, Sheila M.
    Roger, Veronique L.
    Kushwaha, Sudhir S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04) : 359 - 365
  • [6] Impact of 30 Day Readmission After Left Ventricular Assist Device Implantation
    Gupta, Saurabh
    Cogswell, Rebecca J.
    Roy, Samit S.
    Spratt, John R.
    Liao, Kenneth K.
    Martin, Cindy M.
    John, Ranjit
    ASAIO JOURNAL, 2019, 65 (03) : 252 - 256
  • [7] Right heart failure after durable left ventricular assist device implantation
    Miller, Tamari
    Lang, Frederick M.
    Rahbari, Ashkon
    Theodoropoulos, Kleanthis
    Topkara, Veli K.
    EXPERT REVIEW OF MEDICAL DEVICES, 2024, 21 (03) : 197 - 206
  • [8] Flying after left ventricular assist device implantation
    Hanke, Jasmin S.
    Schmack, Bastian
    Merzah, Ali Saad
    Bounader, Karl
    Chatterjee, Anamika
    Mariani, Silvia
    Li, Tong
    Klautzsch, Erik
    Mueller, Florian
    Homann, Katharina
    Schoede, Alexandra
    Haverich, Axel
    Ruhparwar, Arjang
    Schmitto, Jan D.
    Dogan, Guenes
    ARTIFICIAL ORGANS, 2021, 45 (03) : 230 - 235
  • [9] Driving After Left Ventricular Assist Device Implantation
    Hanke, Jasmin S.
    Riebandt, Julia
    Wahabzada, Miena
    Nur, Fatma
    Wahabzada, Angela
    Dogan, Guenes
    Feldmann, Christina
    Haverich, Axel
    Popov, Aron-Friedrich
    Zimpfer, Daniel
    Schmitto, Jan D.
    ARTIFICIAL ORGANS, 2018, 42 (07) : 695 - 699
  • [10] Durable left ventricular assist device implantation in extremely obese heart failure patients
    Lee, Andy Y.
    Tecson, Kristen M.
    Lima, Brian
    Shaikh, Asad F.
    Collier, Justin
    Still, Sasha
    Baxter, Ronald
    DiMaio, John M.
    Felius, Joost
    Carey, Sandra A.
    Gonzalez-Stawinski, Gonzalo V.
    Nauret, Richard
    Wong, Marcus
    Hall, Shelley A.
    Joseph, Susan M.
    ARTIFICIAL ORGANS, 2019, 43 (03) : 234 - 241